Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 58
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Qiuyang Zheng, Xin Wang
Protein & Cell (2024)
Open Access | Times Cited: 24
Cornuside alleviates cognitive impairments induced by Aβ1−42 through attenuating NLRP3-mediated neurotoxicity by promoting mitophagy
Fulin Zhou, Wenwen Lian, Xiaotang Yuan, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Current Progress and Future Directions in Non-Alzheimer’s Disease Tau PET Tracers
Hendris Wongso, Ryuichi Harada, Shozo Furumoto
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 2, pp. 111-127
Closed Access | Times Cited: 2
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
И. Ф. Беленичев, Olena Popazova, Nina Bukhtiyarova, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 108-108
Open Access | Times Cited: 2
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Rajni Daksh, Meby Susan Mathew, Aan Mery Bosco, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 754, pp. 151526-151526
Open Access | Times Cited: 2
Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Dur e Nayab, Fakhar ud Din, Hussain Ali, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7258-7258
Open Access | Times Cited: 23
Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke
Yang Liu, Lauren Guttman, Valina L. Dawson, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116174-116174
Closed Access | Times Cited: 12
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Laura M. De Plano, Alessandra Saitta, Salvatore Oddo, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 719-719
Open Access | Times Cited: 12
Iron quantification in basal ganglia: quantitative susceptibility mapping as a potential biomarker for Alzheimer’s disease – a systematic review and meta-analysis
Sadegh Ghaderi, Sana Mohammadi, Nahid Jashire Nezhad, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 11
omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases
Chelsea X. Alvarado, Mary B. Makarious, Cory A. Weller, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 1, pp. 150-164
Open Access | Times Cited: 9
Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging
Bidur Paudel, Si‐Yeon Jeong, Carolina Pena Martinez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Unraveling Alzheimer’s: the promise of aducanumab, lecanemab, and donanemab
Taha Basit Ameen, Syeda Naveera Kashif, Syed Muhammad Iraj Abbas, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 9
Cell therapy for neurological disorders
Soshana Svendsen, Clive N. Svendsen
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2756-2770
Closed Access | Times Cited: 8
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access | Times Cited: 1
Oxidative/Nitrosative Stress, Apoptosis, and Redox Signaling: Key Players in Neurodegenerative Diseases
Nuray Üremiş, Muhammed Mehdi Üremi̇ş
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Targeting PAAN/MIF nuclease activity in parthanatos-associated brain diseases
Lauren Guttman, Yang Liu, Meilian Liu, et al.
Advances in pharmacology (2025), pp. 1-26
Closed Access | Times Cited: 1
Neuroprotective Effects of Dehydroepiandrosterone Sulphate Against Aβ Toxicity and Accumulation in Cellular and Animal Model of Alzheimer’s Disease
Barbara Vuić, Tina Milos, Erika Kvak, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 432-432
Open Access | Times Cited: 1
The Molecular Mechanisms of Neuroinflammation in Alzheimer’s Disease, the Consequence of Neural Cell Death
Su-Bin Choi, Sehee Kwon, Jihye Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11757-11757
Open Access | Times Cited: 22
DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice
Wenbin Zhang, Yue Huang, Xiaorou Guo, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 21
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
Rishabh Singh, Sanskriti Rai, Prahalad Singh Bharti, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease
Sara Chavoshinezhad, Elmira Beirami, Esmael Izadpanah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115656-115656
Open Access | Times Cited: 15
Eugenol relieves the pathological manifestations of Alzheimer's disease in 5×FAD mice
Minji Jung, Namkwon Kim, Seung Ho Jeon, et al.
Phytomedicine (2023) Vol. 118, pp. 154930-154930
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top